Baxter - 37 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Baxter as of November 16, 2018 is 66.51.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2018 | 70.3160 | 66.8291 | 77.8000 | 61.5600 | 66.5100 | 3.42% |
| 2017 | 57.4364 | 43.7628 | 65.5547 | 43.7628 | 64.3119 | 47.29% |
| 2016 | 42.9734 | 36.1818 | 48.2695 | 33.8358 | 43.6643 | 17.58% |
| 2015 | 36.0043 | 37.7621 | 40.7587 | 31.3156 | 37.1357 | -1.63% |
| 2014 | 36.6684 | 34.6448 | 39.1102 | 33.3229 | 37.7518 | 8.40% |
| 2013 | 34.1908 | 32.9443 | 36.7388 | 31.7580 | 34.8251 | 7.28% |
| 2012 | 27.8361 | 23.9536 | 33.2769 | 23.5289 | 32.4622 | 38.42% |
| 2011 | 25.4218 | 23.4061 | 29.2224 | 22.4013 | 23.4512 | 0.05% |
| 2010 | 22.7704 | 26.3258 | 27.8704 | 18.4581 | 23.4385 | -11.56% |
| 2009 | 24.1276 | 24.3718 | 26.8723 | 20.7536 | 26.5020 | 11.76% |
| 2008 | 26.9442 | 25.1779 | 31.2271 | 21.3539 | 23.7125 | -6.24% |
| 2007 | 23.6965 | 19.9952 | 26.6156 | 19.9221 | 25.2912 | 26.79% |
| 2006 | 17.3941 | 16.2838 | 20.1070 | 15.0485 | 19.9479 | 24.81% |
| 2005 | 15.6034 | 14.4797 | 17.1272 | 13.9569 | 15.9824 | 10.63% |
| 2004 | 12.9502 | 12.3939 | 14.4672 | 11.8147 | 14.4462 | 15.22% |
| 2003 | 10.7227 | 11.5588 | 12.7760 | 7.4775 | 12.5377 | 11.14% |
| 2002 | 17.0503 | 20.9691 | 23.5360 | 9.5644 | 11.2808 | -46.73% |
| 2001 | 18.9194 | 17.4968 | 21.6685 | 15.9098 | 21.1784 | 22.85% |
| 2000 | 13.8050 | 11.8204 | 17.3016 | 9.9774 | 17.2392 | 42.52% |
| 1999 | 12.4735 | 11.9558 | 14.4254 | 11.1971 | 12.0957 | -0.50% |
| 1998 | 10.7256 | 9.2975 | 12.4302 | 9.0304 | 12.1564 | 29.95% |
| 1997 | 9.2152 | 7.3709 | 10.9164 | 7.3709 | 9.3550 | 25.77% |
| 1996 | 7.4159 | 6.8261 | 8.3790 | 6.5604 | 7.4380 | 8.29% |
| 1995 | 5.7446 | 4.4730 | 6.9705 | 4.3140 | 6.8688 | 51.57% |
| 1994 | 3.9801 | 3.7245 | 4.5318 | 3.3983 | 4.5318 | 21.68% |
| 1993 | 4.0301 | 4.6945 | 4.6945 | 3.0608 | 3.7245 | -21.89% |
| 1992 | 5.2294 | 5.6418 | 5.7683 | 4.4993 | 4.7681 | -17.07% |
| 1991 | 4.8118 | 3.8683 | 5.8042 | 3.6211 | 5.7496 | 45.97% |
| 1990 | 3.4326 | 3.5117 | 4.0743 | 2.8593 | 3.9390 | 14.41% |
| 1989 | 2.9221 | 2.3652 | 3.5086 | 2.3652 | 3.4429 | 45.56% |
| 1988 | 2.7401 | 3.0639 | 3.4083 | 2.1994 | 2.3652 | -20.70% |
| 1987 | 3.1621 | 2.4791 | 3.7995 | 2.3969 | 2.9827 | 18.75% |
| 1986 | 2.3680 | 2.0224 | 2.7557 | 1.9898 | 2.5117 | 22.22% |
| 1985 | 1.9062 | 1.7132 | 2.1685 | 1.6310 | 2.0550 | 19.95% |
| 1984 | 2.1267 | 3.0336 | 3.1967 | 1.5657 | 1.7132 | -43.53% |
| 1983 | 3.4906 | 3.0251 | 4.0859 | 2.7883 | 3.0336 | -3.89% |
| 1982 | 2.5308 | 2.2344 | 3.2946 | 2.0387 | 3.1563 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.393B | $10.561B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $126.543B | 19.40 |
| Abbott Laboratories (ABT) | United States | $126.526B | 25.64 |
| Stryker (SYK) | United States | $64.420B | 24.28 |
| Boston Scientific (BSX) | United States | $51.491B | 26.02 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.875B | 15.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.038B | 0.00 |
| ResMed (RMD) | United States | $14.846B | 28.31 |
| Perrigo (PRGO) | Ireland | $8.596B | 13.05 |
| Bio-Rad Laboratories (BIO) | United States | $8.274B | 52.91 |
| Canopy Growth (CGC) | Canada | $8.174B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.270B | 19.88 |
| Aurora Cannabis (ACB) | Canada | $6.172B | 33.68 |
| Haemonetics (HAE) | United States | $5.727B | 50.36 |
| ICU Medical (ICUI) | United States | $4.968B | 27.68 |
| Insulet (PODD) | United States | $4.838B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $4.052B | 0.00 |
| Hutchison China MediTech (HCM) | China | $4.010B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.990B | 0.00 |
| Neogen (NEOG) | United States | $3.294B | 49.88 |
| NuVasive (NUVA) | United States | $3.166B | 29.46 |
| National Vision Holdings (EYE) | United States | $3.024B | 58.49 |
| Quidel (QDEL) | United States | $2.507B | 32.68 |
| Aphria (APHA) | $2.433B | 0.00 | |
| NxStage Medical (NXTM) | United States | $1.933B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.409B | 19.95 |
| AtriCure (ATRC) | United States | $1.241B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.058B | 1524.50 |
| VAREX IMAGING (VREX) | United States | $0.999B | 20.07 |
| Meridian Bioscience (VIVO) | United States | $0.823B | 26.23 |
| Surmodics (SRDX) | United States | $0.794B | 121.41 |
| OraSure Technologies (OSUR) | United States | $0.772B | 43.48 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.756B | 24.24 |
| MacroGenics (MGNX) | United States | $0.740B | 0.00 |
| Cerus (CERS) | United States | $0.716B | 0.00 |
| PetIQ (PETQ) | United States | $0.705B | 20.03 |
| Lantheus Holdings (LNTH) | United States | $0.625B | 19.34 |
| Omeros (OMER) | United States | $0.619B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.540B | 26.52 |
| Owens & Minor (OMI) | United States | $0.535B | 6.05 |
| Insys Therapeutics (INSY) | United States | $0.527B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.521B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.403B | 0.00 |
| Quanterix (QTRX) | United States | $0.376B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.332B | 21.45 |
| Cytosorbents (CTSO) | United States | $0.313B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.264B | 0.00 |
| Surface Oncology (SURF) | United States | $0.225B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.214B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.204B | 275.00 |
| Chimerix (CMRX) | United States | $0.172B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.141B | 7.06 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.123B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.106B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 16.85 |
| Female Health (VERU) | United States | $0.075B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.070B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.066B | 21.07 |
| CAS Medical Systems (CASM) | United States | $0.053B | 0.00 |
| Neurotrope (NTRP) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.029B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.018B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
